Back to Results
First PageMeta Content
Biology / Science / Niemann–Pick disease / Sphingomyelin phosphodiesterase / Clinical trial / Sphingomyelin / Genzyme / Sphingomyelin phosphodiesterase 1 / Niemann-Pick disease / type C / Health / Lipid storage disorders / Rare diseases


Update from Genzyme on Acid Sphingomyelinase Deficiency (ASMD) Clinical Trials November 15, 2012 Genzyme, a Sanofi company, is continuing efforts to develop recombinant human acid sphingomyelinase (rhASM) for the potenti
Add to Reading List

Document Date: 2012-11-21 17:28:28

Open Document

File Size: 299,39 KB

Share Result on Facebook
UPDATE